Publications | Flatiron Health | Hematologic malignancies

Browse every publication tagged Hematologic malignancies

November 2026
Treatment patterns and outcomes post-CAR T failure in LBCL: the "what comes next" question
November 2026
Real-world comparison of biologic features, treatment patterns, and clinical outcomes between younger (≤55 years) and older (>55 years) patients with CLL receiving frontline targeted therapy
November 2026
When MRD matters: clinical interpretation and treatment decision-making after measurable residual disease testing in multiple myeloma
November 2026
Association of lymphopenia with outcomes in diffuse large B cell lymphoma in the era of T-cell directed therapies
November 2026
Frontline treatment and consolidation strategies and associated outcomes in primary central nervous system lymphoma: a large US real-world study
November 2026
Treatment patterns across lines of therapy among patients with newly diagnosed multiple myeloma in the United States
November 2026
Real-world treatment patterns of novel immune-based therapy utilization in relapsed/refractory multiple myeloma: evidence from a contemporary cross-sectional analysis
November 2026
The CAR-T funnel: AI-assisted mapping of patient attrition and barriers across the second-line CAR-T pathway in relapsed/refractory diffuse large B-cell lymphoma
November 2026
Real-world safety and effectiveness of elranatamab in multiple myeloma, including in late-line and BCMA-exposed patients